LCINQ — Lannett Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.32m
- $582.17m
- $340.58m
Annual income statement for Lannett, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 685 | 655 | 546 | 479 | 341 |
| Cost of Revenue | |||||
| Gross Profit | 289 | 244 | 165 | 75.6 | 33.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 555 | 918 | 528 | 726 | 517 |
| Operating Profit | 130 | -263 | 17.4 | -248 | -176 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 51.1 | -346 | -48.6 | -303 | -234 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 37.2 | -272 | -33.4 | -363 | -232 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 28.7 | -272 | -33.4 | -363 | -232 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 28.7 | -272 | -33.4 | -363 | -232 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 7.53 | -2.66 | -0.874 | -21.7 | -16.1 |